Evidence map›Paper›PMID 39308843›Full record

ReviewCureus2024

Apple Vision Pro: A Paradigm Shift in Medical Technology.

Nandan M Shanbhag, Abdulrahman Bin Sumaida, Khalifa Al Shamisi, Khalid Balaraj

Registry-linked trialAbstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07573748 (Apple Vision Pro-Assisted Vascular Identification in Lung Surgery), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07573748 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Apple Vision Pro-Assisted Vascular Identification in Lung Surgery: A Prospective Interventional Study

TypeinterventionalSponsorThe Second People's Hospital of Huai'anRan2026 to 2026Enrolled20ConditionsLung Neoplasms, Mixed RealityArmsApple Vision Pro
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nandan M ShanbhagOncology/Radiation Oncology/Palliative Care, Tawam Hospital, Al Ain, ARE.
Abdulrahman Bin SumaidaOncology/Radiation Oncology, Tawam Hospital, Al Ain, ARE.
Khalifa Al ShamisiFinance, Tawam Hospital, Al Ain, ARE.
Khalid BalarajOncology/Radiation Oncology, Tawam Hospital, Al Ain, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of Apple Vision Pro (AVP) marks a significant milestone in the intersection of technology and healthcare, offering unique capabilities in mixed reality, which Apple terms "spatial computing." This narrative review aims to explore the various applications of AVP in medical technology, emphasizing its impact on patient care, clinical practices, medical education, and future directions. The review synthesizes findings from multiple studies and articles published between January 2023 and May 2024, highlighting AVP's potential to enhance visualization in diagnostic imaging and surgical planning, assist visually impaired patients, and revolutionize medical education through immersive learning environments. Despite its promise, challenges remain in integrating AVP into existing healthcare systems and understanding its long-term impact on patient outcomes. As research continues, AVP is poised to play a pivotal role in the future of medicine, offering a transformative tool for healthcare professionals.

Indexed as

apple vision proartificial intelligenceavplarge language modelmixed realityspatial computingvirtual reality (vr)vr headset

Identifiers

PMID39308843
PMCPMC11413724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.